{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:03:50Z","timestamp":1773389030312,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2T32HL007057-41"],"award-info":[{"award-number":["2T32HL007057-41"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA014236"],"award-info":[{"award-number":["5P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5KL2TR001115-03"],"award-info":[{"award-number":["5KL2TR001115-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.bbmt.2017.06.027","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T14:01:45Z","timestamp":1500300105000},"page":"1949-1954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning"],"prefix":"10.1016","volume":"23","author":[{"given":"Sarah","family":"Anand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Corbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gasparetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwynn D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Rizzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson J.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell E.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.06.027_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0020","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.13136","article-title":"Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia","volume":"168","author":"Barker","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.13802","article-title":"Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols","volume":"172","author":"Hough","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2013.259","article-title":"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT","volume":"28","author":"Ruggeri","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clml.2013.08.006","article-title":"The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation","volume":"14","author":"Mehta","year":"2014","journal-title":"Clin Lymph Myel Leuk"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0050","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bbmt.2014.07.014","article-title":"Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation","volume":"20","author":"Abedin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0055","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbmt.2010.09.009","article-title":"Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning","volume":"17","author":"Kanda","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0065","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/ctrv.2000.0170","article-title":"Chemistry, pharmacology and pharmacokinetics of N,N',N\u201d -triethylenethiophosphoramide (ThioTEPA)","volume":"26","author":"Maanen","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1701103","article-title":"Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice","volume":"21","author":"Down","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0080","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0085","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","article-title":"T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin","volume":"110","author":"Jakubowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajh.24567","article-title":"Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia\u2014a survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"92","author":"Eder","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ejh.12553","volume":"96","author":"Eder","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/bmt.2016.239","article-title":"Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT","volume":"52","author":"Eder","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0110","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0120","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0125","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2012.13","article-title":"Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen","volume":"47","author":"Sanz","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0130","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbmt.2013.09.015","article-title":"Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms","volume":"19","author":"Sanz","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bmt.2010.192","article-title":"Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis","volume":"46","author":"Cutler","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbmt.2013.02.007","article-title":"A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation","volume":"19","author":"Ponce","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0150","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2006.03.007","article-title":"Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation","volume":"12","author":"Parody","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","article-title":"Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation","volume":"22","author":"Ballen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0160","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.2003.04792.x","article-title":"Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults","volume":"124","author":"Hamza","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbmt.2014.02.010","article-title":"Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin","volume":"20","author":"Olson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0170","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bbmt.2014.07.021","article-title":"Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources","volume":"20","author":"Ballen","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.06.027_bib0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2012-08-449108","article-title":"Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia","volume":"121","author":"Scaradavou","year":"2013","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117305773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117305773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:22Z","timestamp":1761058822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117305773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1083879117305773"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.06.027","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}